Another study showed an imbalance in the distribution of TIGIT and CD226 on γδ T cells, with a decrease in CD226+ γδ T cells and an increase in TIGIT+ γδ T cells in patients with AML-DN patients. This evidence concerns the gene CD226 and acute myeloid leukemia.